WO2001056568A1 - Substances therapeutiques ou preventives pour maladies digestives, contenant des derives de diaminotrifluoromethylpyridine - Google Patents
Substances therapeutiques ou preventives pour maladies digestives, contenant des derives de diaminotrifluoromethylpyridine Download PDFInfo
- Publication number
- WO2001056568A1 WO2001056568A1 PCT/JP2001/000614 JP0100614W WO0156568A1 WO 2001056568 A1 WO2001056568 A1 WO 2001056568A1 JP 0100614 W JP0100614 W JP 0100614W WO 0156568 A1 WO0156568 A1 WO 0156568A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- optionally substituted
- substituted
- disease
- phenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU28861/01A AU778111B2 (en) | 2000-01-31 | 2001-01-30 | Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives |
CA2398898A CA2398898C (en) | 2000-01-31 | 2001-01-30 | Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative |
US10/182,374 US6653333B2 (en) | 2000-01-31 | 2001-01-30 | Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives |
KR1020027009789A KR20020070525A (ko) | 2000-01-31 | 2001-01-30 | 디아미노트리플루오로메틸피리딘의 유도체를 함유하는소화기 질환 치료제 또는 예방제 |
IL15096501A IL150965A0 (en) | 2000-01-31 | 2001-01-30 | Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative |
DE60134626T DE60134626D1 (de) | 2000-01-31 | 2001-01-30 | Heilmittel und vorbeugende mittel für verdauungserkrankungen die diaminotrifluoromethylpyridinverbindungen enthalten |
EP01948937A EP1252890B1 (en) | 2000-01-31 | 2001-01-30 | Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives |
NZ520353A NZ520353A (en) | 2000-01-31 | 2001-01-30 | Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative |
IL150965A IL150965A (en) | 2000-01-31 | 2002-07-29 | Therapeutic or prophylactic factor for inflammatory bowel ulcer and Crohn's disease, which results from diaminotrifluoromethylpyridine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-22817 | 2000-01-31 | ||
JP2000022817 | 2000-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001056568A1 true WO2001056568A1 (fr) | 2001-08-09 |
Family
ID=18549065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/000614 WO2001056568A1 (fr) | 2000-01-31 | 2001-01-30 | Substances therapeutiques ou preventives pour maladies digestives, contenant des derives de diaminotrifluoromethylpyridine |
Country Status (15)
Country | Link |
---|---|
US (1) | US6653333B2 (ja) |
EP (1) | EP1252890B1 (ja) |
KR (1) | KR20020070525A (ja) |
CN (1) | CN1277539C (ja) |
AT (1) | ATE399550T1 (ja) |
AU (1) | AU778111B2 (ja) |
CA (1) | CA2398898C (ja) |
DE (1) | DE60134626D1 (ja) |
ES (1) | ES2307626T3 (ja) |
IL (2) | IL150965A0 (ja) |
NZ (1) | NZ520353A (ja) |
RU (1) | RU2266114C2 (ja) |
TW (1) | TWI283578B (ja) |
WO (1) | WO2001056568A1 (ja) |
ZA (1) | ZA200205962B (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004040302A1 (ja) * | 2002-10-30 | 2004-05-13 | Ishihara Sangyo Kaisha, Ltd. | RAPL・Rap1相互作用制御 |
WO2019088214A1 (ja) | 2017-11-02 | 2019-05-09 | 石原産業株式会社 | 徐放性医薬組成物 |
WO2019167979A1 (ja) | 2018-03-01 | 2019-09-06 | 石原産業株式会社 | 保存安定性に優れた医薬組成物 |
WO2020230876A1 (ja) | 2019-05-15 | 2020-11-19 | 石原産業株式会社 | N-(2-エチルスルホニルアミノ-5-トリフルオロメチル-3-ピリジル)シクロヘキサンカルボキサミド・一ナトリウム塩の無水和物結晶体 |
WO2022071233A1 (ja) * | 2020-09-29 | 2022-04-07 | 石原産業株式会社 | 優れた保存効力を示す液状医薬組成物 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5584518B2 (ja) | 2009-05-28 | 2014-09-03 | 石原産業株式会社 | ジアミノトリフルオロメチルピリジン誘導体を含有する抗ショック剤 |
RU2504779C1 (ru) * | 2012-10-08 | 2014-01-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ростовский государственный медицинский университет" Минздравсоцразвития России | Способ оценки эффективности лечения больных язвенным колитом |
US10335390B2 (en) | 2014-09-05 | 2019-07-02 | Symbiomix Therapeutics, Llc | Secnidazole for use in the treatment of bacterial vaginosis |
RU2607160C2 (ru) * | 2015-04-27 | 2017-01-10 | Ирина Вадимовна Козлова | Способ лечения обострений у больных хроническим неспецифическим язвенным колитом |
US11253501B2 (en) * | 2015-06-01 | 2022-02-22 | Lupin Inc. | Secnidazole formulations and use in treating bacterial vaginosis |
JP2018177701A (ja) * | 2017-04-14 | 2018-11-15 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | クローン病を治療するための医薬組成物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229403A (en) * | 1990-07-10 | 1993-07-20 | Ishihara Sangyo Kaisha Ltd. | Diaminotrifluoromethylpyridine derivatives and phospholipase A2 inhibitor containing them |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07126189A (ja) | 1993-09-09 | 1995-05-16 | Takeda Chem Ind Ltd | 抗潰瘍併用療法用製剤 |
JPH08259447A (ja) | 1995-03-24 | 1996-10-08 | Takeda Chem Ind Ltd | コレシストキニン拮抗剤 |
JP3183378B2 (ja) | 1995-06-28 | 2001-07-09 | 参天製薬株式会社 | ムチン産生促進剤 |
JPH09157182A (ja) | 1995-12-06 | 1997-06-17 | Hoechst Japan Ltd | 新規な潰瘍性大腸炎治療剤 |
JPH10101576A (ja) | 1996-10-01 | 1998-04-21 | Nisshin Flour Milling Co Ltd | 消化器疾患治療剤 |
JPH10167985A (ja) | 1996-10-08 | 1998-06-23 | Takeda Chem Ind Ltd | 抗ヘリコバクター剤 |
ZA981430B (en) | 1997-02-28 | 1998-08-24 | Ishihara Sangyo Kaisha | Anticancer composition |
JPH10330346A (ja) | 1997-05-28 | 1998-12-15 | Daiichi Rajio Isotope Kenkyusho:Kk | 直鎖状ニトロン誘導体並びにこれを含有する医薬および試薬 |
JPH1112171A (ja) | 1997-06-19 | 1999-01-19 | Nisshin Flour Milling Co Ltd | 消化器疾患治療薬 |
JPH1192373A (ja) | 1997-09-24 | 1999-04-06 | Taisho Pharmaceut Co Ltd | 胃粘膜保護剤 |
-
2001
- 2001-01-30 ES ES01948937T patent/ES2307626T3/es not_active Expired - Lifetime
- 2001-01-30 WO PCT/JP2001/000614 patent/WO2001056568A1/ja active IP Right Grant
- 2001-01-30 US US10/182,374 patent/US6653333B2/en not_active Expired - Lifetime
- 2001-01-30 AT AT01948937T patent/ATE399550T1/de not_active IP Right Cessation
- 2001-01-30 KR KR1020027009789A patent/KR20020070525A/ko not_active Application Discontinuation
- 2001-01-30 CN CNB018043054A patent/CN1277539C/zh not_active Expired - Fee Related
- 2001-01-30 RU RU2002123373/15A patent/RU2266114C2/ru not_active IP Right Cessation
- 2001-01-30 CA CA2398898A patent/CA2398898C/en not_active Expired - Lifetime
- 2001-01-30 IL IL15096501A patent/IL150965A0/xx active IP Right Grant
- 2001-01-30 NZ NZ520353A patent/NZ520353A/en not_active IP Right Cessation
- 2001-01-30 DE DE60134626T patent/DE60134626D1/de not_active Expired - Lifetime
- 2001-01-30 EP EP01948937A patent/EP1252890B1/en not_active Expired - Lifetime
- 2001-01-30 AU AU28861/01A patent/AU778111B2/en not_active Ceased
- 2001-01-30 TW TW090101811A patent/TWI283578B/zh not_active IP Right Cessation
-
2002
- 2002-07-25 ZA ZA200205962A patent/ZA200205962B/en unknown
- 2002-07-29 IL IL150965A patent/IL150965A/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229403A (en) * | 1990-07-10 | 1993-07-20 | Ishihara Sangyo Kaisha Ltd. | Diaminotrifluoromethylpyridine derivatives and phospholipase A2 inhibitor containing them |
Non-Patent Citations (3)
Title |
---|
LILJA I. ET AL.: "Phospholipase A2 gene expression and activity in histologically normalileal mucosa and in crohn's ileitis", GUT, vol. 37, 1995, pages 380 - 385, XP002938905 * |
NINAMI T., SHONOMURA Y., OKAMOTO M.: "Increased group II phospholipase A2 in colonic mucosa of patients with crohn's disease and ulcerative colitis", GUT, vol. 35, 1994, pages 1593 - 1598, XP002938904 * |
PETERSON J.W. ET AL.: "Phospholipase A2 activating protein and idiopathetic inflammatory bowel disease", GUT, vol. 39, 1996, pages 698 - 704, XP002938906 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004040302A1 (ja) * | 2002-10-30 | 2004-05-13 | Ishihara Sangyo Kaisha, Ltd. | RAPL・Rap1相互作用制御 |
WO2019088214A1 (ja) | 2017-11-02 | 2019-05-09 | 石原産業株式会社 | 徐放性医薬組成物 |
WO2019167979A1 (ja) | 2018-03-01 | 2019-09-06 | 石原産業株式会社 | 保存安定性に優れた医薬組成物 |
EP3760200A4 (en) * | 2018-03-01 | 2021-12-15 | Ishihara Sangyo Kaisha, Ltd. | PHARMACEUTICAL COMPOSITION WITH EXCELLENT STABILITY IN STORAGE |
WO2020230876A1 (ja) | 2019-05-15 | 2020-11-19 | 石原産業株式会社 | N-(2-エチルスルホニルアミノ-5-トリフルオロメチル-3-ピリジル)シクロヘキサンカルボキサミド・一ナトリウム塩の無水和物結晶体 |
WO2022071233A1 (ja) * | 2020-09-29 | 2022-04-07 | 石原産業株式会社 | 優れた保存効力を示す液状医薬組成物 |
KR20230084205A (ko) | 2020-09-29 | 2023-06-12 | 이시하라 산교 가부시끼가이샤 | 우수한 보존 효력을 나타내는 액상 의약 조성물 |
Also Published As
Publication number | Publication date |
---|---|
CA2398898A1 (en) | 2001-08-09 |
EP1252890A1 (en) | 2002-10-30 |
US20030027843A1 (en) | 2003-02-06 |
EP1252890A4 (en) | 2003-05-07 |
ES2307626T3 (es) | 2008-12-01 |
DE60134626D1 (de) | 2008-08-14 |
RU2002123373A (ru) | 2004-03-10 |
AU778111B2 (en) | 2004-11-18 |
IL150965A0 (en) | 2003-02-12 |
IL150965A (en) | 2008-06-05 |
TWI283578B (en) | 2007-07-11 |
RU2266114C2 (ru) | 2005-12-20 |
KR20020070525A (ko) | 2002-09-09 |
ZA200205962B (en) | 2003-08-18 |
AU2886101A (en) | 2001-08-14 |
CN1400900A (zh) | 2003-03-05 |
CA2398898C (en) | 2010-03-30 |
US6653333B2 (en) | 2003-11-25 |
EP1252890B1 (en) | 2008-07-02 |
NZ520353A (en) | 2005-02-25 |
ATE399550T1 (de) | 2008-07-15 |
CN1277539C (zh) | 2006-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU720132B2 (en) | Pharmaceutical compositions | |
JPS60208913A (ja) | 高めた無痛覚を与える製薬製品 | |
EP1642885A1 (en) | Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract | |
WO2001056568A1 (fr) | Substances therapeutiques ou preventives pour maladies digestives, contenant des derives de diaminotrifluoromethylpyridine | |
JPH02196715A (ja) | カテコール誘導体を有効成分として含有する胃腸管の潰瘍、障害およびこれらに類似の症状のための治療または予防剤 | |
TW415843B (en) | Anti-cancer pharmaceutical compositions comprising a diaminotrifluoromethylpyridine derivatives or the pharmaceutically acceptable salts thereof | |
KR0175345B1 (ko) | 장점막 장애 예방 및 치료제 | |
JP4848091B2 (ja) | ジアミノトリフルオロメチルピリジン誘導体を含有する消化器疾患治療剤又は予防剤 | |
IL151009A (en) | Medicinal or prophylactic drug for pulmonary insufficiency containing a history of diaminotrifluoromethylpyridine | |
WO2015178683A1 (ko) | p-당단백질의 저해제 및 p-당단백질의 기질 약물을 포함하는 약제학적 조성물 | |
US20080145409A1 (en) | Composition for the treatment and prevention of peptic ulcer | |
KR100793236B1 (ko) | 대장염 치료용 약학적 조성물 | |
US7125868B2 (en) | Thienothiazine compound having anti-inflammatory and analgesic properties and method of making and using the same | |
WO2019232665A1 (zh) | 一类具有抗癌活性的硫代吲嗪类化合物及其衍生物 | |
WO2019135725A1 (en) | Combinations of selective cox-2 inhibitor nsaids and h2 receptor antagonists for fast treatment of pain and inflammation | |
KR101460828B1 (ko) | 두개골 외상의 치료를 위한 4-시클로프로필메톡시-n-(3,5-디클로로-1-옥시도피리딘-4-일)-5-(메톡시)피리딘-2-카르복스아미드의 용도 | |
JP4993998B2 (ja) | イブプロフェンを含有する医薬組成物 | |
KR20040104658A (ko) | 라푸티딘을 포함하는 치료제 | |
JP2021123530A (ja) | 多発性骨髄腫の治療剤 | |
WO2018117249A1 (ja) | 経口イブプロフェン製剤 | |
JP2005508830A (ja) | ピリジン誘導体を用いる方法 | |
JP2011157298A (ja) | 胃潰瘍治療剤 | |
WO2008088314A2 (en) | A composition for the treatment and prevention of peptic ulcer | |
HU206616B (en) | Process for producing pharmaceutical compositions containing pharmaceutically active tetrahydro-naphtalene derivative | |
JPS5812256B2 (ja) | 胃潰瘍等の治療薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 520353 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001948937 Country of ref document: EP Ref document number: 28861/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002/05962 Country of ref document: ZA Ref document number: 200205962 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 150965 Country of ref document: IL Ref document number: 10182374 Country of ref document: US Ref document number: 018043054 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2398898 Country of ref document: CA Ref document number: 1020027009789 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2002 2002123373 Country of ref document: RU Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027009789 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2001948937 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 520353 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 28861/01 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 520353 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001948937 Country of ref document: EP |